DayaMed

DayaMed is a digital health and analytics company that is committed to improving medication adherence, pharmacy services, and logistics in real-time. Since its establishment in 2014, the company has focused on population health, leveraging its clinical services team, artificial intelligence, real-time sensors, and engagement devices to enhance patient clinical outcomes, lower healthcare expenses, and improve patient experiences. Based in Reno, Nevada, the company also has a global headquarters in Waterloo, Ontario, Canada. DayaMed serves a wide range of clients, including pharmacies, hospitals, health insurance companies, pharmaceutical companies, governments, PBMs, and employers worldwide. The latest investment made in DayaMed was a Seed Round investment at 01 May 2021, and it was facilitated by the Reno Seed Fund. As a prominent player in the healthcare industry, DayaMed's innovative approach to medication adherence and disease management presents an investment opportunity that aligns with the growing demand for digital health solutions. With its focus on utilizing technology to improve patient care and reduce healthcare costs, DayaMed demonstrates the potential for significant impact and growth in the evolving healthcare landscape.